Tuesday, July 23, 2013 6:01 PM
|
CCSVI in Multiple Sclerosis
Big Money, Big Pharma, Big Corruption Multiple Sclerosis drugs are in the headlines once again, as GlaxoSmithKline, a British drug maker, is being investigated by an independent Chinese auditor after internal documents were discovered which showed corruption and falsification of research. Yes, you read that correctly....
|